2.01

0.99% -0.02

After Hours: 2.05 0.04 +1.99%

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.01, with a volume of 1.12M. It is down -0.99% in the last 24 hours and up +6.35% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.03

Open:

$1.99

24h Volume:

1.12M

Relative Volume:

2.45

Market Cap:

$195.93M

Revenue:

$32.38M

Net Income/Loss:

$-21.64M

P/E Ratio:

-7.9857

EPS:

-0.2517

Net Cash Flow:

$-13.78M

1W Performance:

+4.15%

1M Performance:

+6.35%

6M Performance:

-36.19%

1Y Performance:

+13.56%

1-Day Range:

$1.85

$2.015

1-Week Range:

$1.83

$2.04

52-Week Range:

$1.69

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1112)

Industry

Medical Instruments & Supplies (57)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2025-03-03

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.01	197.88M	32.38M	-21.64M	-13.78M	-0.2517
ISRG Intuitive Surgical Inc	468.36	165.94B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.52	44.30B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	80.73	38.96B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.93	38.69B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	228.80	33.61B	5.40B	1.49B	1.78B	10.12

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

01:03 AM

Stereotaxis (STXS) to Acquire Robocath in Multi-Million Dollar D - GuruFocus

01:03 AM

01:02 AM

Stereotaxis Eyes Billions In Market Opportunity With Robocath Takeover - Benzinga

01:02 AM

11:43 AM

Stereotaxis to buy Robocath for up to $45M - MedTech Dive

11:43 AM

11:21 AM

Stereotaxis to Buy Robocath for up to $45M - Medical Product Outsourcing

11:21 AM

08:42 AM

St. Louis robotic surgery firm acquires French competitor - The Business Journals

08:42 AM

08:07 AM

Stereotaxis to Acquire Robocath in Strategic Robotics Deal - TipRanks

08:07 AM

07:22 AM

Stereotaxis to acquire Robocath for up to $45 million By Investing.com - Investing.com Canada

07:22 AM

07:15 AM

Stereotaxis (STXS) plans Robocath acquisition with $20M upfront and $25M earnout - Stock Titan

07:15 AM

07:00 AM

Europe’s only commercial coronary robot joins Stereotaxis in $45M deal - Stock Titan

07:00 AM

Apr 14, 2026

Citizens Initiates Coverage of Stereotaxis (STXS) with Market Outperform Recommendation - MSN

Apr 14, 2026

Stereotaxis, Inc. urges final day visits at EHRA2026 for hands on robotic EP demonstrations - Traders Union

Apr 14, 2026

Apr 13, 2026

Stereotaxis (STXS) CFO awarded 40,000 options at $1.87 strike price - Stock Titan

Apr 13, 2026

Aug Drivers: Is Stereotaxis Inc being accumulated by smart money2026 Levels & Daily Chart Pattern Signal Reports - baoquankhu1.vn

Apr 13, 2026

Inflation Data: Can Stereotaxis Inc keep up with sector leaders2026 Trading Volume Trends & Community Driven Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Stereotaxis, Inc. (AMEX:STXS) Q1 2025 Earnings Call Transcript - MSN

Apr 12, 2026

Stereotaxis, Inc. promotes GenesisX at EHRA2026 kickoff in Paris - Traders Union

Apr 12, 2026

Apr 10, 2026

Bank Watch: Does Stereotaxis Inc align with a passive investing strategy2026 Year in Review & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Apr 10, 2026

Apr 08, 2026

St. Louis-based Stereotaxis gets FDA clearance for new cath lab software platform - The Business Journals

Apr 08, 2026

Stereotaxis wins FDA clearance for Synchrony system, launches platform - MSN

Apr 08, 2026

Stereotaxis bags FDA clearance for next-gen cath lab tech - Indian Pharma Post

Apr 08, 2026

Apr 07, 2026